GlassScriptPhysician profile
Angela Felsing
NPI 1235785403
$2,472.84
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,201 · 2022: $900 · 2023: $241 · 2024: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $487.60 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $365.28 | 2021-2024 | |
| Avanir Pharmaceuticals, INC. | $343.94 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $193.44 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $144.15 | 2022 | |
| Lilly USA, LLC | $129.79 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $108.12 | 2024 | Rexulti |
| Amgen INC. | $94.24 | 2021-2022 | |
| Biogen, INC. | $92.64 | 2021-2022 | |
| Sk Life Science, INC. | $59.44 | 2021-2023 | |
| Sunovion Pharmaceuticals INC. | $47.71 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $45.95 | 2021 | |
| Eisai INC. | $35.57 | 2021 | |
| Ucb, INC. | $35.31 | 2021 | |
| Harmony Biosciences LLC | $34.40 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $33.37 | 2021-2022 | |
| Csl Behring | $29.80 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.11 | 2022 | |
| Medtronic, INC. | $25.34 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $24.04 | 2023 | |
| Kyowa Kirin, INC. | $19.01 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.52 | 2021 | |
| Avion Pharmaceuticals | $18.28 | 2022 | |
| Mallinckrodt Hospital Products INC. | $17.05 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.29 | 2021 | |
| Acorda Therapeutics, INC | $14.39 | 2022 | |
| Neurocrine Biosciences, INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Felsing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.